Literature DB >> 23259810

Kinome-wide activity modeling from diverse public high-quality data sets.

Stephan C Schürer1, Steven M Muskal.   

Abstract

Large corpora of kinase small molecule inhibitor data are accessible to public sector research from thousands of journal article and patent publications. These data have been generated employing a wide variety of assay methodologies and experimental procedures by numerous laboratories. Here we ask the question how applicable these heterogeneous data sets are to predict kinase activities and which characteristics of the data sets contribute to their utility. We accessed almost 500,000 molecules from the Kinase Knowledge Base (KKB) and after rigorous aggregation and standardization generated over 180 distinct data sets covering all major groups of the human kinome. To assess the value of the data sets, we generated hundreds of classification and regression models. Their rigorous cross-validation and characterization demonstrated highly predictive classification and quantitative models for the majority of kinase targets if a minimum required number of active compounds or structure-activity data points were available. We then applied the best classifiers to compounds most recently profiled in the NIH Library of Integrated Network-based Cellular Signatures (LINCS) program and found good agreement of profiling results with predicted activities. Our results indicate that, although heterogeneous in nature, the publically accessible data sets are exceedingly valuable and well suited to develop highly accurate predictors for practical Kinome-wide virtual screening applications and to complement experimental kinase profiling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23259810      PMCID: PMC3569091          DOI: 10.1021/ci300403k

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  29 in total

1.  Selecting screening candidates for kinase and G protein-coupled receptor targets using neural networks.

Authors:  David T Manallack; Will R Pitt; Emanuela Gancia; John G Montana; David J Livingstone; Martyn G Ford; David C Whitley
Journal:  J Chem Inf Comput Sci       Date:  2002 Sep-Oct

Review 2.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 3.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

4.  Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures.

Authors:  Jérôme Hert; Peter Willett; David J Wilton; Pierre Acklin; Kamal Azzaoui; Edgar Jacoby; Ansgar Schuffenhauer
Journal:  Org Biomol Chem       Date:  2004-09-29       Impact factor: 3.876

5.  Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up.

Authors:  David Rogers; Robert D Brown; Mathew Hahn
Journal:  J Biomol Screen       Date:  2005-09-16

Review 6.  Kinomics: characterizing the therapeutically validated kinase space.

Authors:  Michal Vieth; Jeffrey J Sutherland; Daniel H Robertson; Robert M Campbell
Journal:  Drug Discov Today       Date:  2005-06-15       Impact factor: 7.851

7.  Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.

Authors:  Alex M Aronov; Brian McClain; Cameron Stuver Moody; Mark A Murcko
Journal:  J Med Chem       Date:  2008-02-21       Impact factor: 7.446

8.  Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.

Authors:  Paul Bamborough; David Drewry; Gavin Harper; Gary K Smith; Klaus Schneider
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

9.  Chemical fragments as foundations for understanding target space and activity prediction.

Authors:  Jeffrey J Sutherland; Richard E Higgs; Ian Watson; Michal Vieth
Journal:  J Med Chem       Date:  2008-04-04       Impact factor: 7.446

Review 10.  Targeting the cancer kinome through polypharmacology.

Authors:  Zachary A Knight; Henry Lin; Kevan M Shokat
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

View more
  14 in total

1.  Screening of cell cycle fusion proteins to identify kinase signaling networks.

Authors:  Michelle Trojanowsky; Dusica Vidovic; Scott Simanski; Clara Penas; Stephan Schurer; Nagi G Ayad
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth.

Authors:  Hassan Al-Ali; Do-Hun Lee; Matt C Danzi; Houssam Nassif; Prson Gautam; Krister Wennerberg; Bill Zuercher; David H Drewry; Jae K Lee; Vance P Lemmon; John L Bixby
Journal:  ACS Chem Biol       Date:  2015-06-24       Impact factor: 5.100

3.  Improving the Prediction of Potential Kinase Inhibitors with Feature Learning on Multisource Knowledge.

Authors:  Yichen Zhong; Cong Shen; Huanhuan Wu; Tao Xu; Lingyun Luo
Journal:  Interdiscip Sci       Date:  2022-05-10       Impact factor: 3.492

4.  Chemical interrogation of the neuronal kinome using a primary cell-based screening assay.

Authors:  Hassan Al-Ali; Stephan C Schürer; Vance P Lemmon; John L Bixby
Journal:  ACS Chem Biol       Date:  2013-03-19       Impact factor: 5.100

5.  Large-scale integration of small molecule-induced genome-wide transcriptional responses, Kinome-wide binding affinities and cell-growth inhibition profiles reveal global trends characterizing systems-level drug action.

Authors:  Dušica Vidović; Amar Koleti; Stephan C Schürer
Journal:  Front Genet       Date:  2014-09-30       Impact factor: 4.599

6.  UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor.

Authors:  Weihe Zhang; Deborah DeRyckere; Debra Hunter; Jing Liu; Michael A Stashko; Katherine A Minson; Christopher T Cummings; Minjung Lee; Trevor G Glaros; Dianne L Newton; Susan Sather; Dehui Zhang; Dmitri Kireev; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  J Med Chem       Date:  2014-08-06       Impact factor: 7.446

Review 7.  Machine and deep learning approaches for cancer drug repurposing.

Authors:  Naiem T Issa; Vasileios Stathias; Stephan Schürer; Sivanesan Dakshanamurthy
Journal:  Semin Cancer Biol       Date:  2020-01-03       Impact factor: 15.707

8.  Comparability of mixed IC₅₀ data - a statistical analysis.

Authors:  Tuomo Kalliokoski; Christian Kramer; Anna Vulpetti; Peter Gedeck
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

Review 9.  Computational methods for analysis and inference of kinase/inhibitor relationships.

Authors:  Fabrizio Ferrè; Antonio Palmeri; Manuela Helmer-Citterich
Journal:  Front Genet       Date:  2014-06-30       Impact factor: 4.599

10.  Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.

Authors:  Bryce K Allen; Saurabh Mehta; Stewart W J Ember; Ernst Schonbrunn; Nagi Ayad; Stephan C Schürer
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.